What is orphenadrine, including its mechanism of action, indications, adult dosing regimen, recommended duration of therapy, contraindications, adverse effects, and alternative muscle relaxants?

What is Orphenadrine

Orphenadrine is a centrally acting skeletal muscle relaxant structurally similar to diphenhydramine that works through anticholinergic mechanisms rather than direct muscle relaxation, and is used for acute musculoskeletal pain conditions associated with muscle spasm. 1

Mechanism of Action

• The precise mechanism remains unclear, but orphenadrine appears to exert its effects primarily through anticholinergic properties rather than direct skeletal muscle relaxation. 1
• The drug is a monomethylated derivative of diphenhydramine, explaining its structural similarity to antihistamines. 2
• Animal studies demonstrate both antinociceptive (pain-reducing) and muscle relaxant properties, though the clinical relevance of true muscle relaxation versus sedation remains debated. 2

Clinical Indications

• Orphenadrine is indicated for acute painful musculoskeletal conditions associated with muscle spasm, typically as adjunctive therapy. 3
• Human placebo-controlled studies provide some support for mild analgesic effects in painful conditions with muscle spasm, though evidence quality is limited. 2
• The drug is commonly administered both preoperatively and perioperatively in surgical settings. 1

Dosing and Administration

• Available in both oral and intravenous formulations. 1
• A fixed combination product containing orphenadrine 30 mg with diclofenac 75 mg (infusion solution) has been used successfully for acute back pain in inpatient settings. 4
• Combination products with paracetamol (acetaminophen) demonstrate superior efficacy over paracetamol alone in controlled studies. 2

Duration of Therapy

• All skeletal muscle relaxant trials, including those with orphenadrine, were 2 weeks or less in duration, indicating these agents should only be used short-term. 3, 5
• There is insufficient evidence for chronic use of any muscle relaxant for musculoskeletal pain. 6

Contraindications

Orphenadrine is absolutely contraindicated in the following conditions due to its anticholinergic properties: 1

• Gastrointestinal tract obstruction
• Stenosing peptic ulcer disease
• Prostatic hypertrophy or bladder outlet obstruction
• Glaucoma
• Myasthenia gravis

Special Precautions and Warnings

Use with extreme caution in patients with: 1

• Tachycardia
• Cardiac decompensation
• Coronary insufficiency
• Cardiac arrhythmias
• Elderly patients (increased sensitivity to anticholinergic effects)

Adverse Effects

The adverse effect profile is dominated by anticholinergic symptoms: 1

• Central nervous system: Confusion, anxiety, tremors, drowsiness, dizziness
• Cardiovascular: Cardiovascular instability, potential for arrhythmias
• Anticholinergic effects: Urinary retention, dry mouth, constipation
• Serious toxicity: In overdose, orphenadrine can cause seizures resistant to multiple antiepileptics and ventricular tachycardia requiring lidocaine treatment. 7

Drug Interactions

• Orphenadrine potentiates anticholinergic effects when combined with other medications that have anticholinergic properties. 1
• The combination of orphenadrine with other anticholinergic agents increases the risk of confusion, urinary retention, and cardiovascular complications. 1

Perioperative Management

The Society for Perioperative Assessment and Quality Improvement (SPAQI) recommends holding orphenadrine on the day of operation. 1

Alternative Muscle Relaxants

When orphenadrine is contraindicated or not tolerated, consider: 6, 8

• Tizanidine: The most evidence-based alternative with efficacy demonstrated in 8 trials for acute low back pain; preferred by the American College of Physicians due to superior evidence quality. 6
• Methocarbamol: Available in oral and IV formulations; showed benefit in postoperative orthopedic settings when combined with acetaminophen, though elimination is significantly impaired in liver and kidney disease. 1
• Metaxalone: Oral centrally acting agent, but contraindicated in significant hepatic or renal dysfunction. 1

Avoid these alternatives: 6

• Benzodiazepines (diazepam): No proven benefit for musculoskeletal pain with high risks of abuse, falls, and sedation, particularly in older adults. 6
• Baclofen: Only sparse evidence for low back pain; primarily indicated for spasticity from upper motor neuron disorders. 6

Clinical Efficacy Evidence

• Combination products containing orphenadrine with analgesics (paracetamol or NSAIDs) demonstrate superior efficacy compared to analgesics alone. 2
• The combination of orphenadrine/paracetamol is more efficacious than placebo in well-controlled studies. 2
• However, the relative efficacy of fixed combination products versus separate administration of individual sedative and analgesic agents remains unknown. 3

Important Clinical Caveats

• The concept of "muscle relaxant" is somewhat misleading, as these drugs do not directly relax skeletal muscle and likely work primarily through sedative properties. 6
• Acceptable evidence of efficacy is difficult to obtain due to reliance on subjective response measures and inadequately designed clinical studies. 3
• In overdose, orphenadrine plasma levels above 3.55 μg/mL are in the toxic range associated with high mortality, with an elimination half-life of approximately 10.2 hours. 7